Výsledky vyhledávání - "Guarionex Joel, Decastro"

Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial

Autor: Karie Runcie, Moshe Chaim Ornstein, Biren Saraiya, Venkatesh Krishnamurthi, Byron H Lee, Christopher B. Anderson, Guarionex Joel DeCastro, James M. McKiernan, Matthew Dallos, Tina M. Mayer, Melanie Marron, Alexandria Kulik, Eric A. Singer, Mark N. Stein

Publikováno v: Journal of Clinical Oncology. 41:691-691

691 Background: The perioperative safety of cabozantinib and nivolumab in mccRCC, and the optimal timing to hold cabozantinib prior to surgery, are unknown. Methods: In this phase 2 trial, patients with mccRCC are given cabozantinib (40mg daily) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa563934eb9137e812b76c670456b135
https://doi.org/10.1200/jco.2023.41.6_suppl.691

Zobrazit plný text záznamu

A population-based analysis of risk factors and outcomes of prostatic abscess

Autor: Albert S, Ha, Talia A, Helman, Christopher R, Haas, Guarionex Joel, Decastro, Elias S, Hyams

Publikováno v: Prostate cancer and prostatic diseases. 24(4)

Prostate abscess is a severe complication of acute bacterial prostatitis. To date, a population-based analysis of risk factors and outcomes of prostatic abscess has not been performed.Using the National Inpatient Sample from 2010 to 2015, we identifi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::969df78b14ce24f7517b241c3a75010b
https://pubmed.ncbi.nlm.nih.gov/33972703

Zobrazit plný text záznamu

A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder

Autor: Charles G. Drake, Cory Abate-Shen, Guarionex Joel DeCastro, Max M. Kates, Renu K. Virk, Christopher B. Anderson, Bridget James, Wilson Sui, Dara Holder, Jamie S. Pak, Shing M. Lee, James M. McKiernan

Publikováno v: The Journal of urology. 204(2)

For patients with bacillus Calmette-Guérin unresponsive or recurrent/relapsing nonmuscle invasive bladder cancer, multi-agent intravesical trials have been limited. In this study we investigate the safety of intravesical cabazitaxel, gemcitabine and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c93d750e216bb48c237cc57e247281
https://pubmed.ncbi.nlm.nih.gov/32459549

Zobrazit plný text záznamu

Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy

Autor: Charles G. Drake, Mitchell C. Benson, Christopher B. Anderson, Justin T. Matulay, Guarionex Joel DeCastro, Rashed Ghandour, James M. McKiernan, Michael J Lipsky, Alexa R. Meyer, Dennis J. Robins

Publikováno v: Urology. 111:116-121

Objective To investigate survival outcomes of patients with muscle-invasive bladder cancer (MIBC) that demonstrate complete clinical response (cT0) to neoadjuvant chemotherapy (NAC) and then reject subsequent radical cystectomy (RC). Methods A retros

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bad5ff7765350da2f9231af06da43a7
https://doi.org/10.1016/j.urology.2017.09.003

Zobrazit plný text záznamu

MP21-01 SINGLE CELL TRANSCRIPTIONAL PROFILING OF IMMUNE POPULATIONS WITHIN RENAL CELL CARCINOMA TUMOR MICROENVIRONMENT

Autor: Guarionex Joel DeCastro, Vinson Wang, Erin C. Bush, Peter A. Sims, Nivedita Chowdhury, Aleksandar Obradovic, David H. Aggen, Hongxu Ding, James M. McKiernan, Charles G. Drake, Andrea Califano, Christopher B. Anderson

Publikováno v: Journal of Urology. 201

INTRODUCTION AND OBJECTIVES:Recent development of drugs that block the programmed death-1 and cytotoxic T-lymphocyte antigen-4 interaction within the tumor microenvironment has led to improvements ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ff97f0ae706437344f3b9fd2dfb34ae1
https://doi.org/10.1097/01.ju.0000555529.56881.26

Zobrazit plný text záznamu

Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database

Autor: Ifeanyi Onyeji, Justin T. Matulay, Wilson Sui, Maxwell B. James, Guarionex Joel DeCastro, Sven Wenske, Marissa C. Theofanides

Publikováno v: International Journal of Urology. 23:745-750

OBJECTIVES To determine whether perioperative blood transfusion is associated with worse 30-day postoperative outcomes in radical cystectomy patients. METHODS Utilizing the National Surgical Quality Improvement Program database, we identified 2934 pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0f8a7f3b44276cf4b66df3b96de681
https://doi.org/10.1111/iju.13152

Zobrazit plný text záznamu

Plný text ve formátu HTML

Oncologic outcomes of complete transurethral resection prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer

Autor: Christopher B. Anderson, Helena Vila Reyes, Guarionex Joel DeCastro, Christopher R. Haas, Mitchell C. Benson, James M. McKiernan, Jamie Sungmin Pak

Publikováno v: Journal of Clinical Oncology. 38:e17029-e17029

e17029 Background: Neoadjuvant chemotherapy (NAC) prior to radical cystectomy (RC) is the standard of care for muscle-invasive bladder cancer (MIBC). Prior studies have shown that pT0 response at RC can be attributed to NAC and high-quality transuret

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ce046f7ed877dce003243183d70fda28
https://doi.org/10.1200/jco.2020.38.15_suppl.e17029

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání